Financial Reports Latest Updates Industry Maps Economic Calendar

Cadre Holdings, Inc. (CDRE) Annual Reports

Q: Where can I read Cadre Holdings, Inc. (CDRE) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

Cadre Holdings, Inc. is listed on NYSE, classified by the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： NYSE
Fiscal year end： 12/31
SEC CIK： 1860543 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$207.1M	$157.1M	+31.8%
Operating income	$22.5M	$14.7M	+53.0%
Net income	$11.4M	$12.2M	-6.6%
EPS (diluted)	$0.26	$0.30	-13.3%

Company guidance
	Period	Range
Adjusted EBITDA	FY	$749M – $769M

Figures are the company’s own outlook as stated in its earnings release, not analyst estimates.

Source: SEC EDGAR (XBRL company facts); guidance from Form 8-K Exhibit 99.1

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 207 mn Net income 11.4 mn

Show table：Income statement

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	—	—	106	108	111	115	98.7	104	104	118	112	124	112	121	125	125	138	144	109	176	130	157	156	167	155	207
Gross profit	—	—	40.0	39.8	44.0	48.2	39.3	39.2	40.2	43.2	43.7	48.5	46.6	50.8	53.6	49.8	57.6	58.6	40.0	77.2	56.1	64.3	66.6	72.6	60.2	87.1
Operating income	—	—	12.8	9.29	15.4	15.4	11.5	9.32	-14.5	8.16	10.3	12.7	11.2	15.9	16.7	12.7	12.0	19.9	5.43	29.4	13.6	14.7	18.7	20.4	7.49	22.5
Net income	4.25	12.0	6.45	15.8	6.86	6.82	-5.31	4.29	-10.2	4.45	4.94	6.60	7.00	11.0	11.1	9.59	6.93	12.6	3.66	13.0	9.25	12.2	10.9	11.7	1.98	11.4

Balance sheet

Quarterly · In mn (USD)

Total assets 917 mn Total liabilities 571 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	—	117	—	—	144	160	144	175	188	197	199	212	237	246	269	295	286	328	333	381	386	366	319	348
Total assets	—	—	—	283	—	—	302	312	321	369	375	392	389	400	421	431	599	621	617	653	656	794	792	770	880	917
Current liabilities	—	—	—	62.5	—	—	77.5	74.6	75.9	76.4	74.4	78.9	75.4	78.4	89.7	95.2	95.6	93.0	95.1	94.1	93.7	106	106	105	141	162
Total liabilities	—	—	—	274	—	—	295	223	225	223	219	226	220	219	231	234	329	321	316	341	339	462	452	452	544	571
Equity	-27.6	-15.4	-8.12	8.85	16.0	23.1	7.34	88.6	96.0	146	157	166	169	181	190	197	271	299	300	312	318	332	340	318	336	347

Cash flow

Quarterly · In mn (USD)

Operating 22.1 mn Investing -13.8 mn Financing 4.39 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	—	—	28.2	17.2	16.8	11.9	2.28	9.11	8.92	16.1	4.48	16.9	12.7	15.6	18.0	26.9	2.14	11.1	-5.21	23.7	17.4	2.59	22.5	21.3	22.5	22.1
Investing	—	—	14.1	5.72	-0.79	-0.72	-0.72	-0.61	-20.7	-36.8	-0.46	-1.65	-0.58	-1.62	-1.84	-2.48	-143	-2.49	-0.99	-1.31	-1.31	-91.0	-0.85	-3.20	-156	-13.8
Financing	—	—	-42.3	-22.6	-1.49	-13.4	-1.43	9.76	-13.0	40.3	3.86	-6.75	-9.30	-6.60	-2.28	-6.54	140	10.1	-7.05	9.84	-7.81	90.8	-7.59	-43.8	52.9	4.39
Cash at period end	—	—	2.48	2.87	17.4	15.2	15.3	33.9	9.88	28.9	36.4	45.3	48.3	55.8	69.4	87.7	87.0	106	93.0	125	133	137	151	123	41.3	54.0

Profitability

Quarterly · %

Gross margin 42.1% Operating margin 10.8% Net margin 5.5%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	—	—	37.8%	37.0%	39.8%	42.1%	39.8%	37.9%	38.5%	36.6%	39.2%	39.3%	41.7%	41.9%	42.8%	39.9%	41.8%	40.6%	36.6%	43.9%	43.1%	40.9%	42.7%	43.4%	38.7%	42.1%
Operating margin	—	—	12.1%	8.6%	14.0%	13.5%	11.7%	9.0%	-13.9%	6.9%	9.3%	10.3%	10.0%	13.1%	13.4%	10.2%	8.7%	13.8%	5.0%	16.7%	10.4%	9.3%	12.0%	12.2%	4.8%	10.8%
Net margin	—	—	6.1%	14.7%	6.2%	6.0%	-5.4%	4.1%	-9.7%	3.8%	4.4%	5.3%	6.3%	9.1%	8.8%	7.7%	5.0%	8.7%	3.3%	7.4%	7.1%	7.8%	7.0%	7.0%	1.3%	5.5%

Returns & leverage

Quarterly · %

ROE 10.6% ROA 4.2% Debt ratio 62.2%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	434.4%	—	936.9%	—	26.0%	-7.8%	-8.0%	4.3%	4.6%	17.3%	18.1%	20.6%	21.3%	17.5%	16.7%	13.4%	14.2%	13.1%	12.1%	14.2%	14.0%	11.3%	10.6%
ROA	—	—	—	13.6%	—	—	8.0%	4.3%	-1.4%	-1.8%	1.0%	1.6%	6.5%	7.7%	9.0%	9.4%	7.8%	7.9%	6.3%	6.7%	6.1%	5.4%	6.4%	6.2%	4.8%	4.2%
Debt ratio	—	—	—	96.9%	—	—	97.6%	71.6%	70.1%	60.4%	58.3%	57.7%	56.4%	54.9%	54.8%	54.3%	54.8%	51.8%	51.3%	52.3%	51.6%	58.1%	57.0%	58.7%	61.8%	62.2%

EPS

Quarterly · US$

EPS US$0.26

Show table：EPS

Item	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	0.23	0.58	0.25	0.25	-0.19	0.14	-0.30	0.12	0.13	0.18	0.19	0.29	0.29	0.25	0.18	0.31	0.09	0.32	0.23	0.30	0.27	0.23	0.05	0.26

Revenue & profit

Year-to-date · In mn (USD)

Revenue 363 mn Net income 13.4 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 917 mn Total liabilities 571 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 44.6 mn Investing -170 mn Financing 57.3 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 40.6% Operating margin 8.3% Net margin 3.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 10.6% ROA 4.2% Debt ratio 62.2%

EPS

Year-to-date · US$

EPS US$0.31

Revenue & profit

Annual · In mn (USD)

Revenue 610 mn Net income 44.1 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2020	2021	2022	2023	2024	2025
Revenue	—	427	458	483	568	610
Gross profit	—	171	176	201	233	260
Operating income	—	51.7	16.7	56.5	66.8	67.3
Net income	38.5	12.7	5.82	38.6	36.1	44.1

Balance sheet

Annual · In mn (USD)

Total assets 770 mn Total liabilities 452 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2020	2021	2022	2023	2024	2025
Current assets	117	160	197	246	328	366
Total assets	283	312	392	431	653	770
Current liabilities	62.5	74.6	78.9	95.2	94.1	105
Total liabilities	274	223	226	234	341	452
Equity	8.85	88.6	166	197	312	318

Cash flow

Annual · In mn (USD)

Operating 63.7 mn Investing -96.4 mn Financing 31.6 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2020	2021	2022	2023	2024	2025
Operating	—	40.1	46.4	73.2	31.8	63.7
Investing	—	-2.83	-59.6	-6.52	-147	-96.4
Financing	—	-6.60	24.5	-24.7	153	31.6
Cash at period end	2.87	33.9	45.3	87.7	125	123

Profitability

Annual · %

Gross margin 42.5% Operating margin 11.0% Net margin 7.2%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2020	2021	2022	2023	2024	2025
Gross margin	—	40.0%	38.4%	41.6%	41.1%	42.5%
Operating margin	—	12.1%	3.6%	11.7%	11.8%	11.0%
Net margin	—	3.0%	1.3%	8.0%	6.4%	7.2%

Returns & leverage

Annual · %

ROE 14.0% ROA 6.2% Debt ratio 58.7%

Show table：Returns & leverage

Item	2020	2021	2022	2023	2024	2025
ROE	434.4%	26.0%	4.6%	21.3%	14.2%	14.0%
ROA	13.6%	4.3%	1.6%	9.4%	6.7%	6.2%
Debt ratio	96.9%	71.6%	57.7%	54.3%	52.3%	58.7%

EPS

Annual · US$

EPS US$1.03

Show table：EPS

Item	2020	2021	2022	2023	2024	2025
EPS（US$）	—	0.45	0.13	1.02	0.90	1.03

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read Cadre Holdings, Inc. (CDRE) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.